Eli Lilly (LLY) Current Assets (2009 - 2026)

Eli Lilly (LLY) has reported Current Assets for 18 consecutive years, with $54.8 billion the latest figure, recorded in Q1 2026.

• Current Assets for Q1 2026 came in at $54.8 billion, up 32.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $54.8 billion (up 32.9% YoY), and the FY2025 annual result was $55.6 billion, up 69.91% from the prior year.
• Current Assets was $54.8 billion for Q1 2026 at Eli Lilly, down from $55.6 billion in the prior quarter.
• Over five years, Current Assets peaked at $62.1 billion in Q3 2025 and troughed at $17.0 billion in Q1 2022.
• Average Current Assets over 5 years is $32.0 billion, with a median of $25.7 billion recorded in 2023.
• Year-over-year, Current Assets decreased 2.26% in 2022 and soared 97.58% in 2025.
• Over 5 years, Current Assets stood at $18.0 billion in 2022, then jumped by 42.65% to $25.7 billion in 2023, then climbed by 27.26% to $32.7 billion in 2024, then soared by 69.91% to $55.6 billion in 2025, then decreased by 1.43% to $54.8 billion in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $54.8 billion in Q1 2026, $55.6 billion in Q4 2025, and $62.1 billion in Q3 2025.